Key Takeaways SPCX shares ended Friday’s session down 1% at $152.71, despite securing a substantial $946 million NASA contract extension. The space company received approval for three additio
Shares of SpaceX (SPCX) finished Friday’s trading session at $152.71, declining 1.36% despite significant corporate developments. The stock fluctuated between $149.93 and $156.60 throughout the day, maintaining a considerable premium over its 2026 low of $104.83.
Space Exploration Technologies Corp., SPCX
The downward movement occurred despite positive news from NASA, which granted SpaceX an additional three astronaut transportation missions through its Commercial Crew program. This contract modification adds $946 million to the company’s order book.
According to NASA’s announcement, the newly awarded missions include Crew-15, Crew-16, and Crew-17. This expansion brings SpaceX’s total mission count under the program to 17 flights.
$SPCX WINS $946M NASA AWARD FOR THREE MORE CREW MISSIONS
NASA awarded SpaceX three additional astronaut flights to the International Space Station covering Crew-15, Crew-16 and Crew-17.
The missions will run through 2030 and include launch, in-orbit operations, return,… pic.twitter.com/9MZHQyscTX
— Wall St Engine (@wallstengine) September 18, 2026
The expanded agreement encompasses comprehensive services including ground operations, launch execution, orbital operations, spacecraft return and recovery, cargo delivery, and emergency evacuation capabilities. NASA confirmed the program’s cumulative value now reaches $5.92 billion.
The agreement extends through 2030, with mission readiness targets set for 2027 and 2028. SpaceX initially earned NASA certification for crewed spaceflight operations in November 2020.
This contract addition follows SpaceX’s disclosure of $7.81 billion in second-quarter revenue. The figure represents a 91.9% surge compared to the prior-year period, based on MarketBeat data.
The company posted a quarterly loss of $0.09 per stock unit, which exceeded analyst expectations of a $0.26 loss. SpaceX continues operating with negative earnings per share.
Institutional investment activity persists, with Corient Private Wealth establishing a fresh position valued at approximately $5.09 million through acquiring 29,814 SPCX stock units in the second quarter.
MarketBeat data shows 26 analysts recommending Buy, eight rating Hold, and seven advising Sell. The consensus price target sits at $221.42, implying approximately 45% upside from Friday’s close.
Market participants now turn their focus to Starship Flight 14. SpaceX recently adjusted the target launch date from September 22 to September 28, pending final regulatory authorization.
This mission aims to achieve Starship’s inaugural orbital flight. Current flight plans include approximately six complete Earth orbits during a mission duration approaching 10 hours.
The flight profile also includes deployment of 26 Starlink V3 satellites. Each satellite unit delivers one terabit per second of network throughput capacity.
The six-day schedule adjustment contributed to Friday’s negative price action. SpaceX has not issued a public statement explaining the launch date modification.
From a technical analysis standpoint, Invezz highlighted an ascending triangle formation on the two-hour timeframe chart. The analysis also confirmed SPCX trading above its 50-period moving average, with $200 identified as a potential breakout threshold.
SPCX has appreciated from approximately $104.60 in August to current levels above $150. The 50-day moving average currently stands near $134.69, according to MarketBeat.
Looking ahead, the September 28 Starship launch represents the nearest scheduled milestone for market observers. SpaceX emphasizes that mission execution remains contingent upon receiving regulatory authorization.
The post SpaceX (SPCX) Stock Dips Despite Securing Nearly $1 Billion NASA Contract appeared first on Blockonomi.
